摘要
目的探讨慢性心力衰竭多项指标与非慢性心衰组的差异,为今后慢性心力衰竭的早期发现、早期诊断提供一些基本的理论依据,以降低心力衰竭的死亡率。方法 2012年6月到2012年12月本院共收集心力衰竭患者50例,非心力衰竭患者31例,依次对二组的多项指标做统计学分析。结果心衰患者与非心衰患者的综合比较发现,在CHOL、TG、HDL-C、LDL-C、ALT以及AST等生化指标上并没有特异性,在ANG-II、ET-1、IL-β以及TNF四个指标上,可以较为明显的看出,心衰组均明显的高于其他组,在ANG-II,CYPA心衰组的值明显的高于非心衰组。结论慢性心力衰竭并不能通过其血清常规生化指标来反应,而指标特征主要表现在ANG-II、ET-1、IL-β、CYPA以及TNF中。
Objective To investigate the difference in a number of indicators of chronic heart failure with chronic heart failure group,for the future of chronic heart failure early discovery,early diagnosis provides some basic theoretical basis,in order to reduce the mortality rate of heart failure. Methods From June 2012 to December 2012,collected data of 50 patients with heart failure and 31 pationts with non-heart failure,then analyed indicators of two groups do above. Results The patients with heart failure found that comprehensive non-heart failure patients and not specific CHOL,TG,HDL-C,LDL-C,ALT and AST and other biochemical markers,ANG-II,ET-1,IL-β and TNF four indicators Could be seen more obvious,the heart failure group were significantly higher than the other group,after inspection ANG-II,ET-1,IL-β P-value was less than 0.05 CYPA heart failure group was significantly higher than the non-heart failure group. Conclusion Chronic heart failure,the ordinary serum biochemical checks and do not reflect the disease if an indicator of the patients in the ANG-II,ET-1,IL-β and TNF 4 indicators higher than other first consider chronic heart failure patients.
出处
《中国实用医药》
2013年第18期22-23,共2页
China Practical Medicine
关键词
慢性心衰
临床指标学
Chronic heart failure
Clinical indicators
